-
![5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis](/abs-image/US/2003/08/14/US20030153600A1/abs.jpg.150x150.jpg)
公开(公告)号：US20030153600A1
公开(公告)日：2003-08-14
申请号：US10342380
申请日：2003-01-14
Applicant: Merck & Co., Inc.
Inventor： Louis S. Crocker , Ian W. Davies , Richard G. Osifchin , Andrew Kotliar
IPC: A61K031/444 , C07D41/04
CPC classification number: C07D213/61
Abstract: This invention encompasses the Form V polymorph of Compound A of structural formula: 1 which is useful in the treatment of cyclooxygenase-2 mediated diseases. The invention encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising the Form V polymorph of Compound A. The invention also encompasses a process for synthesizing the Form V polymorph of Compound A.
Search Results
1
records
(took 0.028 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
